

THYMOSIN BETA 4, PENTADECAPEPTIDE 10 MG INJECTION
Drug Class: Dual Healing Peptide
Composition:
- Active Substance: Thymosin Beta 4 (5 mg), Pentadecapeptide (5 mg)
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
TB 500/BPC 157 combines two powerful peptides—Thymosin Beta 4 and Pentadecapeptide—in a single 10 mg (5 mg each) vial. Produced by Peptide Hubs, this formula is widely used in research for accelerated tissue healing, inflammation reduction, and enhanced recovery from musculoskeletal injuries.
TB 500 is a synthetic analog of Thymosin Beta‑4, known for stimulating angiogenesis and actin regulation. BPC 157, a fragment of gastric juice, promotes tendon and ligament repair. According to a peer-reviewed study in PubMed, BPC 157 significantly enhances wound healing—a compelling synergy when combined with TB 500.
This peptide duo is administered via subcutaneous injection, typically dosed at 2–5 mg of each peptide 2–3 times per week during an initial loading phase, then tapered for maintenance protocols tailored to specific research aims.
For comprehensive recovery protocols, researchers often combine this blend with:
Generally well-tolerated in lab studies. Possible mild reactions include injection site redness or transient fatigue. It's essential to follow sterile technique in all administrations.
This product is supplied by a trusted provider of lab-grade peptide blends renowned for purity and formulation quality. Ideal for researchers focusing on recovery and regenerative studies.
The combination supports synergistic healing—TB 500 promotes angiogenesis and cell migration, while BPC 157 accelerates tendon and ligament repair.
Typical protocols use 2–5 mg of each peptide, 2–3 times weekly during loading, then reduced for maintenance; subcutaneous injection is standard.
Yes. It's often combined with peptides like Epitalon, MOTS‑c, or GHK‑CU for enhanced recovery and longevity research outcomes.
Side effects are minimal; occasional injection site irritation, fatigue, or mild headaches have been reported. Always use sterile technique.
Yes, it is legal for research use in the USA. It is not approved for human therapeutic use and should be handled per research protocols only.
Please log in to write TB 500/BPC 157 10 mg review.
THYMOSIN BETA-4 5 MG INJECTION
Drug Class: Tissue Healing & Recovery Peptide
Composition:
- Active Substance: Thymosin Beta-4
- Concentration: 5 mg/vial
Form: Powder
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
THYMOSIN BETA 4 5 MG INJECTION
Drug Class: Human Peptide Hormone
Composition:
- Active Substance: Thymosin Beta 4
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
THYMOSIN BETA 4 10 MG INJECTION
Drug Class: Human Peptide Hormone
Composition:
- Active Substance: Thymosin Beta 4
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Stealth Labs USA
Tested in Laboratory: View Lab Report
Shipped Without Label!